BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 28402325)

  • 1. The bioenergetics of inflammation: insights into obesity and type 2 diabetes.
    Keane KN; Calton EK; Carlessi R; Hart PH; Newsholme P
    Eur J Clin Nutr; 2017 Jul; 71(7):904-912. PubMed ID: 28402325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cells of innate and adaptive immunity in type 2 diabetes and obesity].
    Guzmán-Flores JM; López-Briones S
    Gac Med Mex; 2012; 148(4):381-9. PubMed ID: 22976756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on immune dysregulation in obesity-related insulin resistance.
    Daryabor G; Kabelitz D; Kalantar K
    Scand J Immunol; 2019 Apr; 89(4):e12747. PubMed ID: 30593678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.
    McPhee JB; Schertzer JD
    Clin Sci (Lond); 2015 Dec; 129(12):1083-96. PubMed ID: 26464517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus.
    Richardson VR; Smith KA; Carter AM
    Immunobiology; 2013 Dec; 218(12):1497-504. PubMed ID: 23816302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of immune cells in obesity induced low grade inflammation and insulin resistance.
    Asghar A; Sheikh N
    Cell Immunol; 2017 May; 315():18-26. PubMed ID: 28285710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
    Tam CS; Redman LM
    Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus.
    El Mesallamy HO; Hamdy NM; Mostafa DM; Amin AI
    J Interferon Cytokine Res; 2014 Mar; 34(3):179-86. PubMed ID: 24195710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive immunity in obesity and insulin resistance.
    Sell H; Habich C; Eckel J
    Nat Rev Endocrinol; 2012 Dec; 8(12):709-16. PubMed ID: 22847239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue as an immunological organ.
    Grant RW; Dixit VD
    Obesity (Silver Spring); 2015 Mar; 23(3):512-8. PubMed ID: 25612251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of metabolism by the innate immune system.
    Lackey DE; Olefsky JM
    Nat Rev Endocrinol; 2016 Jan; 12(1):15-28. PubMed ID: 26553134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of Adipose Tissue during Metabolic Syndrome.
    Ghazarian M; Luck H; Revelo XS; Winer S; Winer DA
    Turk Patoloji Derg; 2015; 31 Suppl 1():172-80. PubMed ID: 26177326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the evidence for macrophage presence in skeletal muscle and its relation to insulin resistance in obese mice and humans: a systematic review protocol.
    Bhatt M; Rudrapatna S; Banfield L; Bierbrier R; Wang PW; Wang KW; Thabane L; Samaan MC
    BMC Res Notes; 2017 Aug; 10(1):374. PubMed ID: 28789665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective.
    Pereira JADS; da Silva FC; de Moraes-Vieira PMM
    J Diabetes Res; 2017; 2017():4527980. PubMed ID: 29082258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.
    Aravindhan V; Anand G
    Am J Trop Med Hyg; 2017 Dec; 97(6):1650-1661. PubMed ID: 29141759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of adipose tissue immune cells in obesity and low-grade inflammation.
    Mraz M; Haluzik M
    J Endocrinol; 2014 Sep; 222(3):R113-27. PubMed ID: 25006217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex immunological and inflammatory network of adipose tissue in obesity.
    Apostolopoulos V; de Courten MP; Stojanovska L; Blatch GL; Tangalakis K; de Courten B
    Mol Nutr Food Res; 2016 Jan; 60(1):43-57. PubMed ID: 26331761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.